AMSA Pharm-free Scorecard 2010
D Tulane University School of Medicine
City: New Orleans State: LA

Overall Tulane submits a weak policy. While the policy does discuss many of the domains, it does not effectively place meaningful restrictions on the business interactions between industry and faculty in such a manner to prevent potential conflicts of interest.



This institution did not provide any new or additional for the 2012-13 AMSA PharmFree Scorecard. This institution's evaluation was last updated: 03/16/2011

Gifts & Meals 1 Policy does not ban on-site meals, other limits placed on gifts or on-site meals are not significant.
Consulting relationships 1 While consulting relationships must be disclosed at least annually, without prior approval, there is no policy that requires payment commensurate with the task or that the relationship be described in a formal contract.
Industry-funded speaking relationships 1 All speaking arrangements must be disclosed, but the policy lacks a prohibition on participation in speakers bureaus, or limitations on the length of speaking engagments.
Disclosure 1 While the policy does require annual disclosure of all outside consulting relationships it only requires disclosure of financial interests greater than $10,000 or 5% of the company, this level is too high. A higher score would be possible if a lower financial interest level was used or if all clinicians were required to disclose to their patients as appropriate.
Pharmaceutical samples 1 No policy provided.
Purchasing & Formularies 1 While the policy does use the P&T committee as an example of a potential conflict of interest, there is no formalized policy surrounding P&T committees and the annual disclosure baseline of $10,000 is too high to be effective.
Industry Sales Representatives 2 Industry sales representatives may not be in patient care areas.
On-campus Education 1 No policy provided.
Attendance at Industry-Sponsored Lectures & Meetings Off-Campus 1 Very limited policy with unclear restrictions or goals.
Industry Support for Scholarships & Funds for Trainees 1 The policy places no restrictions or oversight on industry scholarships.
Medical school curriculum 0 No curriculum provided.
Do the policies specify an oversight mechanism? Yes Oversight is designated.
Are there explicit sanctions for noncompliance? Yes Sanctions for non-compliance are referenced.
What the results mean...
3Model policy
2Good progress toward model policy
1No policy, or policy unlikely to have a substantial effect on behavior
0Did not report
N/APolicy not relevant to this institution (e.g., does not make purchasing decisions)